FGF-21 improves glucose uptake and glycogen synthesis of insulin-resistant liver cells

Progress in Biochemistry and Biophysics

Volumn 36, Issue 10, 2009, Pages 1327-1333

  Ming Yao, Liu ^a   Wen Fei, Wang ^a   Yi Xue, Yu ^a   Yu Ting, Hou ^a   Gui Ping, Ren ^a   De Shan, Li ^a  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

Author keywords

Cell model; FGF 21; HepG2 cell line; Insulin resistance

Indexed keywords

EID: 74549159625     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2009.00238     Document Type: Article

References (18)

1. Kharitonenkov A, Shiyanova T L, Li D S, et al. FGF-21 as a novel metabolic regulator. J Clin Invest, 2005, 115 (6):1627-1635
2. Kharitonenkov A, Wroblewski V J, Koester A, et al. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology, 2007, 148 (2):774-781
3. Coskun T, Bina H A, Schneider M A, et al. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology, 2008, 149 (12):6018-6027
4. Zheng X F, Jiang C L. Letters in Biotechnology, 2006, 17 (6):942-944
5. Zhang R X, Jia Z P, Li M X, et al. Chin Pharmac Bull, 2008, 24 (7):971-976
6. Chen Q, Xia Y P, Qiu Z Y. Chin Pharmac Bull, 2006, 22 (2):248-251
7. Chen Q, Xia Y P, Qiu Z Y. Chin Pharmac Bull, 2006, 22 (4):460-464
8. Ge T F, Law P Y, Wong H Y, et al. Gatifloxacin affects GLUT1 gene expression and disturbs glucose homeostasis in vitro. Eur J Pharmacol, 2007, 573(1-3):70-74
9. Chun Y, Yin Z D. Glycogen assay for diagnosis of female genital Chlamydia atrachomatis infection. J Clin Mictobiol, 1998, 36 (4):1081-1082
10. Widdas W F. Old and new concepts of the membrane transport for glucose in cells. Biochim Biophys Acta, 1988, 947 (3):385-404
11. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 2004, 27 (5):1047-1053
12. Girard J. Insulin resistance: role in type 2 diabetes. Diabete Metab. 1994, 20(3Pt2):330-336
13. Moller D E. New drug targets for type 2 diabetes and the metabolic syndrome. Nature, 2001, 414 (6865):821-827
14. Wang W F, Li X K, Li D S. Chin Pharmac Bull, 2009, 25 (4):433-435
15. Ciaraldi T P, Goldberg M, Odom R, et al. In vitro effects of amylin on carbohydrate metabolism in liver cells. Diabetes, 1992, 41 (8):975-981
16. Frittitta L, Sbraccia P, Costanzo B V, et al. High insulin levels do not influence PC-1 gene expression and protein content in human muscle tissue and hepatoma cells. Diabetes Metab Res Rev, 2000, 16 (1):26-32
17. Kosaki A, Webster N J. Effect of dexamethasone on the alternative splicing of the insulin receptor mRNA and insulin action in HepG2 hepatoma cells. J Biol Chem, 1993, 268 (29):21990-21996
18. Yang G Z, Gao X P, Yan J F, et al. SiChuan J Anatomy, 2003, 11 (1):12-15